- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有6家主力机构披露2026-06-30报告期持股数据，持仓量总计325.77万股，占流通A股0.57%
- 波段诊断：
-
技术面诊股
诊断结果：5.4技术面打败了55%的股票
技术面评分前10的股票
近期的平均成本为38.74元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为38.74元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"38.74","date":1784536315,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，接近行业平均水平。
[{"date":"2026.07.21","stock":"-1.93","trade":"-1.38","ind":"1.79"},{"date":"2026.07.20","stock":"2.51","trade":"0.06","ind":"0.85"},{"date":"2026.07.17","stock":"-2.65","trade":"-4.74","ind":"-3.05"},{"date":"2026.07.16","stock":"0.57","trade":"1.47","ind":"-1.85"},{"date":"2026.07.15","stock":"-1.70","trade":"2.87","ind":"-0.29"},{"date":"2026.07.14","stock":"2.50","trade":"1.54","ind":"1.36"},{"date":"2026.07.13","stock":"3.72","trade":"2.88","ind":"-2.06"},{"date":"2026.07.10","stock":"-2.14","trade":"1.37","ind":"-1.00"},{"date":"2026.07.09","stock":"0.55","trade":"-0.25","ind":"1.65"},{"date":"2026.07.08","stock":"1.14","trade":"0.73","ind":"-0.49"},{"date":"2026.07.07","stock":"-1.40","trade":"-3.32","ind":"-1.26"},{"date":"2026.07.06","stock":"0.30","trade":"0.48","ind":"-0.06"},{"date":"2026.07.03","stock":"2.23","trade":"1.67","ind":"0.37"},{"date":"2026.07.02","stock":"2.01","trade":"1.31","ind":"-2.03"},{"date":"2026.07.01","stock":"2.98","trade":"4.04","ind":"0.44"},{"date":"2026.06.30","stock":"-1.98","trade":"-2.41","ind":"0.50"},{"date":"2026.06.29","stock":"6.96","trade":"3.70","ind":"1.16"},{"date":"2026.06.26","stock":"-3.92","trade":"-3.12","ind":"-2.26"},{"date":"2026.06.25","stock":"-2.58","trade":"-1.85","ind":"0.23"},{"date":"2026.06.24","stock":"0.42","trade":"-2.01","ind":"0.11"},{"date":"2026.06.23","stock":"-0.05","trade":"2.18","ind":"-1.37"}]
达仁堂,上证指数,中药指数
压力支撑
该股压力位为38.55元，支撑位为37.77元。
[{"text":"\u538b\u529b\u4f4d","value":"38.55","date":1784563200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"37.77","date":1784563200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.5资金面打败了66%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体无进出。
更新时间：07月21日 17:19
| 机构今日流向(万元) | -1178.93 | 机构5日流向(万元) | 1005.04 |
| 机构10日流向(万元) | 5380.04 | 机构20日流向(万元) | 2618.78 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少972.19万股，其中基金净增仓5家，主力净减仓183家，暂未发现中长期投资价值。
截止2026-06-30，共6家主力机构（基金6家），持仓量总计325.77万股，占流通A股0.57%
其中，基金持仓与2025-12-31相比：
增仓：5家 ，增持 40.53万股
减仓：0家 ，减持 0万股
新出现在主力名单中：1家 ，持有0.14万股
从主力名单中消失：184家 ，原持有1012.86万股
其中，基金持仓与2025-12-31相比：
增仓：5家 ，增持 40.53万股
减仓：0家 ，减持 0万股
新出现在主力名单中：1家 ，持有0.14万股
从主力名单中消失：184家 ，原持有1012.86万股
消息面诊股
诊断结果：4.3消息面打败了12%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 达仁堂：7月20日获融资买入1125.68万元
2026-07-21 - 近200只股票股息率超5% 18只高股息股7月以来
2026-07-21 - 达仁堂：7月17日获融资买入1139.90万元
2026-07-18 - 达仁堂：7月16日获融资买入1702.86万元
2026-07-17 - 达仁堂：7月15日获融资买入2130.97万元
2026-07-16 - 深夜95个医药公布业绩，47个暴雷，这17个高质量
2026-07-15 - 达仁堂：2026年7月31日召开2026年第一次临
2026-07-15 - 达仁堂：7月14日获融资买入2197.38万元
2026-07-15 - 达仁堂：预计2026年上半年净利润同比下降68%到
2026-07-14 - 喜报！津药达仁堂100款产品纳入新版国家基药目录
2026-07-14
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2026-07-16 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2026-07-15 |
| 一般消息 | 高管变动 | 因个人原因 | 2026-07-10 |
| 一般消息 | 高管变动 | 任期届满 | 2026-06-25 |
| 一般消息 | 资产重组 | 公司股权转让 | 2026-05-20 |
| 一般消息 | 重大事项 | 关联交易 | 2026-05-16 |
| 一般消息 | 募资投向 | 2026-04-02 | |
| 利好 | 分红转增 | 10派23.4元(含税) | 2026-03-31 |
| 一般消息 | 重大事项 | 关联交易 | 2026-03-31 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-12-15 |
| 利好 | 分红转增 | 10派24.5元(含税) | 2025-10-31 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-15 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：7.8行业面打败了99%的股票
中药行业最新资金流向
近10日来该行业走势不明显，明显跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，明显跑赢大盘。
[{"date":"2026.07.21","price":"1.79","value":"-1.38"},{"date":"2026.07.20","price":"0.85","value":"0.06"},{"date":"2026.07.17","price":"-3.05","value":"-4.74"},{"date":"2026.07.16","price":"-1.85","value":"1.47"},{"date":"2026.07.15","price":"-0.29","value":"2.87"},{"date":"2026.07.14","price":"1.36","value":"1.54"},{"date":"2026.07.13","price":"-2.06","value":"2.88"},{"date":"2026.07.10","price":"-1.00","value":"1.37"},{"date":"2026.07.09","price":"1.65","value":"-0.25"},{"date":"2026.07.08","price":"-0.49","value":"0.73"},{"date":"2026.07.07","price":"-1.26","value":"-3.32"},{"date":"2026.07.06","price":"-0.06","value":"0.48"},{"date":"2026.07.03","price":"0.37","value":"1.67"},{"date":"2026.07.02","price":"-2.03","value":"1.31"},{"date":"2026.07.01","price":"0.44","value":"4.04"},{"date":"2026.06.30","price":"0.50","value":"-2.41"},{"date":"2026.06.29","price":"1.16","value":"3.70"},{"date":"2026.06.26","price":"-2.26","value":"-3.12"},{"date":"2026.06.25","price":"0.23","value":"-1.85"},{"date":"2026.06.24","price":"0.11","value":"-2.01"},{"date":"2026.06.23","price":"-1.37","value":"2.18"}]
上证指数,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 陇神戎发 | 81.82% | 31.81% | 6.3分 |
| 2 | 珍宝岛 | 28.81% | 28.01% | 5.4分 |
| 3 | 片仔癀 | 28.01% | 14.56% | 6.2分 |
| 4 | 上海凯宝 | 27.33% | 3.90% | 5.4分 |
| 5 | - | 19.40% | 20.09% | 分 |
| 6 | 众生药业 | 18.26% | -13.10% | 6.6分 |
| 8 | 天士力 | 15.07% | 9.39% | 6.7分 |
| 10 | 东阿阿胶 | 12.69% | 4.04% | 6.0分 |
| 12 | 羚锐制药 | 11.94% | -1.28% | 6.3分 |
| 14 | 济川药业 | 11.57% | 7.68% | 6.4分 |
| 16 | 葵花药业 | 8.72% | 2.24% | 5.6分 |
| 18 | 红日药业 | 8.12% | 0.30% | 5.1分 |
| 20 | 华润江中 | 7.61% | 3.35% | 6.0分 |
| 22 | 广誉远 | 6.79% | -2.05% | 6.2分 |
| 24 | 亚宝药业 | 6.21% | -0.61% | 6.0分 |
| 26 | 昆药集团 | 6.17% | -1.46% | 5.7分 |
| 28 | 奇正藏药 | 5.79% | -0.99% | 5.9分 |
| 30 | 云南白药 | 5.50% | 2.30% | 6.1分 |
| 32 | 华润三九 | 4.91% | 0.48% | 6.1分 |
| 34 | 千金药业 | 4.63% | -1.12% | 5.6分 |
| 36 | 步长制药 | 3.27% | -0.50% | 5.6分 |
| 38 | 马应龙 | 2.07% | -1.79% | 5.7分 |
| 40 | 盘龙药业 | 1.54% | -5.19% | 5.0分 |
| 42 | 精华制药 | 1.22% | -2.93% | 5.7分 |
| 44 | 方盛制药 | 0.32% | -3.34% | 5.4分 |
| 46 | 益佰制药 | -0.92% | -6.63% | 5.1分 |
| 48 | 健民集团 | -1.24% | 3.29% | 6.2分 |
| 50 | 振东制药 | -1.63% | -4.73% | 5.0分 |
| 52 | 新光药业 | -2.30% | -5.00% | 5.1分 |
| 54 | ST金花 | -4.61% | -7.52% | 5.0分 |
| 56 | 华森制药 | -6.90% | -13.57% | 4.7分 |
| 58 | 新天药业 | -7.59% | -6.19% | 4.8分 |
| 60 | ST嘉应 | -12.13% | -12.39% | 4.4分 |
| 62 | ST万邦 | -16.15% | -10.79% | 5.8分 |
| 64 | 康惠股份 | -22.30% | -21.28% | 4.9分 |
| 66 | *ST香雪 | -31.48% | -8.03% | 4.5分 |
| 68 | 粤万年青 | -38.54% | -17.64% | 4.8分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 4/107 ， 9/107。
[{"date":"2026-03-31","value":"5.80","vol":"2.21"},{"date":"2025-12-31","value":"28.52","vol":"-2.33"},{"date":"2025-09-30","value":"25.54","vol":"4.80"},{"date":"2025-06-30","value":"23.18","vol":"4.03"},{"date":"2025-03-31","value":"4.66","vol":"2.24"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
5.80 | 28.52 | 25.54 | 23.18 | 4.66 |
| 行业(%) | 2.21 | -2.33 | 4.80 | 4.03 | 2.24 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"77.71","vol":"55.05"},{"date":"2025-12-31","value":"74.02","vol":"52.85"},{"date":"2025-09-30","value":"74.98","vol":"53.29"},{"date":"2025-06-30","value":"74.67","vol":"53.82"},{"date":"2025-03-31","value":"73.86","vol":"54.48"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
77.71 | 74.02 | 74.98 | 74.67 | 73.86 |
| 行业(%) | 55.05 | 52.85 | 53.29 | 53.82 | 54.48 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 21/107 ， 25/107。
[{"date":"2026-03-31","value":"4.12","vol":"-5.58"},{"date":"2025-12-31","value":"-32.70","vol":"-6.76"},{"date":"2025-09-30","value":"-34.59","vol":"-7.84"},{"date":"2025-06-30","value":"-33.15","vol":"-7.78"},{"date":"2025-03-31","value":"-30.22","vol":"-7.40"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
4.12 | -32.70 | -34.59 | -33.15 | -30.22 |
| 行业(%) | -5.58 | -6.76 | -7.84 | -7.78 | -7.40 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"13.24","vol":"1.06"},{"date":"2025-12-31","value":"-4.41","vol":"-80.25"},{"date":"2025-09-30","value":"167.73","vol":"-2.78"},{"date":"2025-06-30","value":"193.08","vol":"2.25"},{"date":"2025-03-31","value":"-3.38","vol":"-37.69"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
13.24 | -4.41 | 167.73 | 193.08 | -3.38 |
| 行业(%) | 1.06 | -80.25 | -2.78 | 2.25 | -37.69 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 26/107 ， 52/107。
[{"date":"2026-03-31","value":"0.14","vol":"0.12"},{"date":"2025-12-31","value":"0.44","vol":"0.47"},{"date":"2025-09-30","value":"0.33","vol":"0.35"},{"date":"2025-06-30","value":"0.22","vol":"0.24"},{"date":"2025-03-31","value":"0.13","vol":"0.13"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.14 | 0.44 | 0.33 | 0.22 | 0.13 |
| 行业(次) | 0.12 | 0.47 | 0.35 | 0.24 | 0.13 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.31","vol":"0.59"},{"date":"2025-12-31","value":"1.06","vol":"2.34"},{"date":"2025-09-30","value":"0.74","vol":"1.72"},{"date":"2025-06-30","value":"0.54","vol":"1.17"},{"date":"2025-03-31","value":"0.31","vol":"0.59"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.31 | 1.06 | 0.74 | 0.54 | 0.31 |
| 行业(次) | 0.59 | 2.34 | 1.72 | 1.17 | 0.59 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"27.86","vol":"5.83"},{"date":"2025-12-31","value":"-10.36","vol":"30.77"},{"date":"2025-09-30","value":"10.06","vol":"10.53"},{"date":"2025-06-30","value":"11.06","vol":"22.82"},{"date":"2025-03-31","value":"24.43","vol":"2.06"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 27.86 | -10.36 | 10.06 | 11.06 | 24.43 |
| 行业 | 5.83 | 30.77 | 10.53 | 22.82 | 2.06 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.95","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.71","vol":"1.03"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.95 | - | 0.71 | - |
| 行业 | 0.00 | 1.00 | 0.00 | 1.03 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 12/107 ， 4/107。
[{"date":"2026-03-31","value":"2.16","vol":"2.97"},{"date":"2025-12-31","value":"1.59","vol":"2.94"},{"date":"2025-09-30","value":"2.81","vol":"3.09"},{"date":"2025-06-30","value":"2.06","vol":"2.94"},{"date":"2025-03-31","value":"2.00","vol":"3.03"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
2.16 | 1.59 | 2.81 | 2.06 | 2.00 |
| 行业 | 2.97 | 2.94 | 3.09 | 2.94 | 3.03 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.96","vol":"2.23"},{"date":"2025-12-31","value":"0.58","vol":"2.15"},{"date":"2025-09-30","value":"1.08","vol":"2.24"},{"date":"2025-06-30","value":"1.37","vol":"2.15"},{"date":"2025-03-31","value":"1.11","vol":"2.24"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
0.96 | 0.58 | 1.08 | 1.37 | 1.11 |
| 行业 | 2.23 | 2.15 | 2.24 | 2.15 | 2.24 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 31/107 ， 33/107。
[{"date":"2026-03-31","value":"27.92","vol":"31.94"},{"date":"2025-12-31","value":"39.26","vol":"32.43"},{"date":"2025-09-30","value":"22.11","vol":"31.59"},{"date":"2025-06-30","value":"31.53","vol":"32.45"},{"date":"2025-03-31","value":"26.38","vol":"31.91"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
27.92 | 39.26 | 22.11 | 31.53 | 26.38 |
| 行业(%) | 31.94 | 32.43 | 31.59 | 32.45 | 31.91 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.39","vol":"0.66"},{"date":"2025-12-31","value":"0.65","vol":"0.67"},{"date":"2025-09-30","value":"0.28","vol":"0.76"},{"date":"2025-06-30","value":"0.46","vol":"0.75"},{"date":"2025-03-31","value":"0.36","vol":"0.74"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.39 | 0.65 | 0.28 | 0.46 | 0.36 |
| 行业(%) | 0.66 | 0.67 | 0.76 | 0.75 | 0.74 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以增持为主，认为该股票有一定投资价值。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 华创证券 | 2026-05-15 | 增持 | |
| 国海证券 | 2026-05-06 | 买入 | |
| 东北证券 | 2026-04-24 | 增持 |
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"8.62","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"9.87","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"22.29","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"21.31","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"10.79","blueLineValue":"1.40","type":"YC"}]